CSIMarket
 


Pmv Pharmaceuticals Inc   (PMVP)
Other Ticker:  
 

Cumulative Pmv Pharmaceuticals Inc 's Leverage Ratio for Trailing Twelve Months Period

PMVP's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

PMVP Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -9.03 % -21.36 % -21.13 % -20.27 % -19.62 %
Y / Y Total Liabilities Growth -1.58 % 3.45 % 2.69 % 5.52 % 23.72 %
Leverage Ratio for Trailing Twelve Months Period 0.1 0.1 0.09 0.09 0.08
Total Ranking # 172 # 183 # 186 # 191 # 206
Seq. Equity Growth 9.09 % -5.37 % -6.44 % -5.81 % -5.7 %
Seq. Total Liabilities Growth -4.06 % 2.61 % -2.03 % 2.06 % 0.83 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to debt repayement of -4.06% Pmv Pharmaceuticals Inc has not changed Leverage Ratio for Trailing Twelve Months Period in the III. Quarter to 0.1, a new company high.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 60 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Pmv Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are PMVP's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 61
Sector # 89
S&P 500 # 159


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.1 0.07 0.03
(Sep 30 2023)   (Jun 30 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Virpax Pharmaceuticals Inc   0.28 
Biohaven Ltd   0.28 
Chinook Therapeutics Inc   0.28 
Repare Therapeutics Inc   0.28 
Ampio Pharmaceuticals inc   0.27 
Geovax Labs Inc   0.27 
Abcellera Biologics Inc   0.26 
Verve Therapeutics Inc   0.26 
Hepion Pharmaceuticals inc   0.26 
Pyxis Oncology Inc   0.26 
Monopar Therapeutics Inc   0.26 
Fsd Pharma Inc   0.26 
Iveric Bio Inc   0.26 
Inozyme Pharma Inc   0.25 
Prothena Corporation Public Limited Company  0.25 
Procyon Corporation  0.25 
Akouos inc   0.25 
Allakos Inc   0.25 
Vascular Biogenics Ltd   0.24 
Kronos Bio Inc   0.24 
Annexon Inc   0.24 
Lumos Pharma Inc   0.24 
United Therapeutics Corporation  0.24 
Zynerba Pharmaceuticals Inc   0.24 
Lianbio  0.24 
Dyne Therapeutics Inc   0.23 
Clever Leaves Holdings Inc   0.23 
Regeneron Pharmaceuticals Inc   0.23 
Erasca Inc   0.23 
Galmed Pharmaceuticals Ltd   0.23 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com